OTRK.NASDAQOntrak, INC

Form 4: Ontrak, Inc. Executive Granted Stock Options Following Stockholder Approval

Sentiment:

SEC Form 4 Filing


Mary Louise Osborne, Chief Commercial Officer of Ontrak, Inc., was granted stock options for 5,000,000 shares following stockholder approval of the stock incentive plan.

Summary

  • On September 12, 2024, Mary Louise Osborne, Chief Commercial Officer of Ontrak, Inc., filed a Form 4.
  • The filing reports a transaction that occurred on September 10, 2024, where Osborne was granted an option to buy 5,000,000 shares of Ontrak, Inc. common stock at an exercise price of $0.2227 per share.
  • The option was granted on June 21, 2024, by the compensation committee, contingent on stockholder approval of the stock incentive plan, which was obtained on September 10, 2024.
  • 50% of the shares will vest one year after the grant date, and the remaining shares will vest in six equal installments every six months over the subsequent three years, contingent on continuous service.

Sentiment

Score: 7

Explanation: The document indicates a standard executive compensation practice, suggesting stability and alignment of interests. The vesting schedule promotes long-term commitment, which is generally viewed positively.

Positives

  • The grant of stock options to the Chief Commercial Officer aligns her interests with those of the shareholders.
  • The vesting schedule incentivizes long-term commitment and performance.

Future Outlook

The vesting schedule suggests an expectation of continued service and contribution from the Chief Commercial Officer over the next four years.

Industry Context

Stock option grants are a common form of executive compensation in publicly traded companies, particularly in growth-oriented sectors like healthcare technology, to align management's interests with shareholder value creation.

Comparison to Industry Standards

  • Stock option grants are a standard component of executive compensation packages in publicly traded companies.
  • The size of the grant (5,000,000 shares) and the vesting schedule (50% after one year, then in six-month installments) are within typical ranges for similar-sized companies and executive roles.
  • Companies like Teladoc Health and Livongo (prior to its acquisition) have used similar stock option plans to incentivize their executives.

Stakeholder Impact

  • Shareholders may view the option grant positively as it aligns executive interests with company performance.
  • Employees may see it as a sign of confidence in the company's future.

Key Dates

DateDescription
06/21/2024Option granted by the compensation committee, subject to stockholder approval.
09/10/2024Stockholder approval of the stock incentive plan obtained; transaction date of option grant.
09/12/2024Date of Form 4 filing.
06/21/2025First vesting date (50% of shares).
06/21/2031Expiration date of the options.

Keywords

stock options, Form 4, Ontrak, OTRK, insider trading, executive compensation, beneficial ownership, Mary Louise Osborne, Chief Commercial Officer

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.